433 related articles for article (PubMed ID: 31352078)
1. YAP1-mediated pancreatic stellate cell activation inhibits pancreatic cancer cell proliferation.
Xiao Y; Zhang H; Ma Q; Huang R; Lu J; Liang X; Liu X; Zhang Z; Yu L; Pang J; Zhou L; Liu T; Wu H; Liang Z
Cancer Lett; 2019 Oct; 462():51-60. PubMed ID: 31352078
[TBL] [Abstract][Full Text] [Related]
2. Galectin-3 Mediates Tumor Cell-Stroma Interactions by Activating Pancreatic Stellate Cells to Produce Cytokines via Integrin Signaling.
Zhao W; Ajani JA; Sushovan G; Ochi N; Hwang R; Hafley M; Johnson RL; Bresalier RS; Logsdon CD; Zhang Z; Song S
Gastroenterology; 2018 Apr; 154(5):1524-1537.e6. PubMed ID: 29274868
[TBL] [Abstract][Full Text] [Related]
3. LncRNA PWAR6 regulates proliferation and migration by epigenetically silencing YAP1 in tumorigenesis of pancreatic ductal adenocarcinoma.
Huang S; Li Y; Hu J; Li L; Liu Z; Guo H; Jiang B; Chen J; Li J; Xiang X; Deng J; Xiong J
J Cell Mol Med; 2021 May; 25(9):4275-4286. PubMed ID: 33834618
[TBL] [Abstract][Full Text] [Related]
4. GPR68, a proton-sensing GPCR, mediates interaction of cancer-associated fibroblasts and cancer cells.
Wiley SZ; Sriram K; Liang W; Chang SE; French R; McCann T; Sicklick J; Nishihara H; Lowy AM; Insel PA
FASEB J; 2018 Mar; 32(3):1170-1183. PubMed ID: 29092903
[TBL] [Abstract][Full Text] [Related]
5. A nicotine-induced positive feedback loop between HIF1A and YAP1 contributes to epithelial-to-mesenchymal transition in pancreatic ductal adenocarcinoma.
Ben Q; An W; Sun Y; Qian A; Liu J; Zou D; Yuan Y
J Exp Clin Cancer Res; 2020 Sep; 39(1):181. PubMed ID: 32894161
[TBL] [Abstract][Full Text] [Related]
6. Integrin α11 in pancreatic stellate cells regulates tumor stroma interaction in pancreatic cancer.
Schnittert J; Bansal R; Mardhian DF; van Baarlen J; Östman A; Prakash J
FASEB J; 2019 May; 33(5):6609-6621. PubMed ID: 30808244
[TBL] [Abstract][Full Text] [Related]
7. The role of S100A9 in the interaction between pancreatic ductal adenocarcinoma cells and stromal cells.
Kung PJ; Lai TY; Cao J; Hsu LC; Chiang TC; Ou-Yang P; Tsai CY; Tsai YF; Lin CW; Chen CC; Tsai MK; Tien YW; Lee CY
Cancer Immunol Immunother; 2022 Mar; 71(3):705-718. PubMed ID: 34374812
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic stellate cell secreted IL-6 stimulates STAT3 dependent invasiveness of pancreatic intraepithelial neoplasia and cancer cells.
Nagathihalli NS; Castellanos JA; VanSaun MN; Dai X; Ambrose M; Guo Q; Xiong Y; Merchant NB
Oncotarget; 2016 Oct; 7(40):65982-65992. PubMed ID: 27602757
[TBL] [Abstract][Full Text] [Related]
9. Global targetome analysis reveals critical role of miR-29a in pancreatic stellate cell mediated regulation of PDAC tumor microenvironment.
Dey S; Liu S; Factora TD; Taleb S; Riverahernandez P; Udari L; Zhong X; Wan J; Kota J
BMC Cancer; 2020 Jul; 20(1):651. PubMed ID: 32660466
[TBL] [Abstract][Full Text] [Related]
10. BAG3-positive pancreatic stellate cells promote migration and invasion of pancreatic ductal adenocarcinoma.
Yuan Y; Jiang JY; Wang JM; Sun J; Li C; Liu BQ; Yan J; Meng XN; Wang HQ
J Cell Mol Med; 2019 Aug; 23(8):5006-5016. PubMed ID: 31119886
[TBL] [Abstract][Full Text] [Related]
11. The critical roles of activated stellate cells-mediated paracrine signaling, metabolism and onco-immunology in pancreatic ductal adenocarcinoma.
Fu Y; Liu S; Zeng S; Shen H
Mol Cancer; 2018 Feb; 17(1):62. PubMed ID: 29458370
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of endogenous SPARC enhances pancreatic cancer cell growth: modulation by FGFR1-III isoform expression.
Chen G; Tian X; Liu Z; Zhou S; Schmidt B; Henne-Bruns D; Bachem M; Kornmann M
Br J Cancer; 2010 Jan; 102(1):188-95. PubMed ID: 19920824
[TBL] [Abstract][Full Text] [Related]
13. Paracrine IL-6 signaling mediates the effects of pancreatic stellate cells on epithelial-mesenchymal transition via Stat3/Nrf2 pathway in pancreatic cancer cells.
Wu YS; Chung I; Wong WF; Masamune A; Sim MS; Looi CY
Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):296-306. PubMed ID: 27750041
[TBL] [Abstract][Full Text] [Related]
14. Inhibiting YAP expression suppresses pancreatic cancer progression by disrupting tumor-stromal interactions.
Jiang Z; Zhou C; Cheng L; Yan B; Chen K; Chen X; Zong L; Lei J; Duan W; Xu Q; Li X; Wang Z; Ma Q; Ma J
J Exp Clin Cancer Res; 2018 Mar; 37(1):69. PubMed ID: 29587800
[TBL] [Abstract][Full Text] [Related]
15. Retinoic acid-induced pancreatic stellate cell quiescence reduces paracrine Wnt-β-catenin signaling to slow tumor progression.
Froeling FE; Feig C; Chelala C; Dobson R; Mein CE; Tuveson DA; Clevers H; Hart IR; Kocher HM
Gastroenterology; 2011 Oct; 141(4):1486-97, 1497.e1-14. PubMed ID: 21704588
[TBL] [Abstract][Full Text] [Related]
16. Persistent activation of pancreatic stellate cells creates a microenvironment favorable for the malignant behavior of pancreatic ductal adenocarcinoma.
Tang D; Wang D; Yuan Z; Xue X; Zhang Y; An Y; Chen J; Tu M; Lu Z; Wei J; Jiang K; Miao Y
Int J Cancer; 2013 Mar; 132(5):993-1003. PubMed ID: 22777597
[TBL] [Abstract][Full Text] [Related]
17. The prognostic significance of cancer-associated fibroblasts in pancreatic ductal adenocarcinoma.
Park H; Lee Y; Lee H; Kim JW; Hwang JH; Kim J; Yoon YS; Han HS; Kim H
Tumour Biol; 2017 Oct; 39(10):1010428317718403. PubMed ID: 29025374
[TBL] [Abstract][Full Text] [Related]
18. Fibronectin acts as a molecular switch to determine SPARC function in pancreatic cancer.
Munasinghe A; Malik K; Mohamedi F; Moaraf S; Kocher H; Jones L; Hill NJ
Cancer Lett; 2020 May; 477():88-96. PubMed ID: 32113990
[TBL] [Abstract][Full Text] [Related]
19. Soluble factors from stellate cells induce pancreatic cancer cell proliferation via Nrf2-activated metabolic reprogramming and ROS detoxification.
Wu YS; Looi CY; Subramaniam KS; Masamune A; Chung I
Oncotarget; 2016 Jun; 7(24):36719-36732. PubMed ID: 27167341
[TBL] [Abstract][Full Text] [Related]
20. Multiplex quantitative analysis of stroma-mediated cancer cell invasion, matrix remodeling, and drug response in a 3D co-culture model of pancreatic tumor spheroids and stellate cells.
Hwang HJ; Oh MS; Lee DW; Kuh HJ
J Exp Clin Cancer Res; 2019 Jun; 38(1):258. PubMed ID: 31200779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
